Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Nov 01, 2012 11:39am
220 Views
Post# 20550060

Quiet period here...

Quiet period here...

No trading yet today...odd...bargain hunters or 'stock manager' working the bid/asks. Stock has been kept in a tight range...easy to do on low volume. 'The market' awaits good news.

On the surface, it appears the company is maintaining a very low key stance... keeping in character. Seems the direction will be a string of licensing agreements starting with Shire and Abbott. Add the pending reseach progess news from Texas. Sooner or later, someone has to act.

As we know, several pharmas are having/have been in discussions wth BTI for many months. If any preliminary buy out chatter has arisen, I am guessing it just doesn't even begin to match the potential of cumulative, multiple licensing agreements and follow up income streams at this time. I suspect that the dam wll break when initial deals are soon  announced, backed up by increasingly undeniable scientific endorsement.

November should be very exciting

Bullboard Posts